Table 3.
Changes in anterior chamber cell and vitreous haze severity among studied patients
| Inflammation score | Mean ± SD change from baselinea | |||
|---|---|---|---|---|
|
|
||||
| Nb | 1 month | Nb | 3 months | |
| Anterior chamber cell gradec | ||||
| Implanted eyes | 108 | 0.056 ± 0.593 | 131 | 0.000 ± 0.632 |
| Non-implanted eyes | 33 | 0.152 ± 1.064 | 38 | 0.211 ± 1.234 |
| Pd | 0.0084 | 0.0002 | ||
| Adjusted vitreous haze gradec | ||||
| Implanted eyes | 99 | −0.256 ± 0.706 | 131 | −0.248 ± 0.714 |
| Non-implanted eyes | 32 | −0.083 ± 0.738 | 38 | 0.250 ± 0.745 |
| Pd | 0.2613 | 0.0005 | ||
a
Notes: Changes from grade assessed at the most recent examination prior to cataract surgery;
b
eyes without missing data;
c
see text for definition;
d
comparison between implanted and non-implanted eyes.
Abbreviation: SD, standard deviation.